Apogee Therapeutics, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
Apogee Therapeutics, Inc. (APGE) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of -1.90% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2026-03-02
- Apogee Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2025 was -1.90%.
- Apogee Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2024 was -1.50%.
- Apogee Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2023 was -1.50%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 11 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | -1.90% 10-K · filed 2026-03-02 | ||
| 2024-12-31 | -1.50% 10-K · filed 2026-03-02 | ||
| 2023-12-31 | -1.50% 10-K · filed 2026-03-02 | 1.50% 10-K · filed 2024-03-05 | |
| 2022-12-31 | 1.10% 10-K · filed 2024-03-05 |